In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Keyword analysis reflects current research themes, hotspots, and future directions. High-frequency keywords included b-cell lymphoma, chemotherapy, FDG-PET/CT, lymphoma, positron-emission-tomography, ...

The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...

For this purpose, we fused the PE38 toxin with the specific C5 sdAb antibody, previously developed by our group for canine B-cell lymphoma. This resulted in a stable and highly specific C5-PE38 ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...

Tet1/3 are dispensable for CD8 effector and memory T cell fate during peripheral T cell priming. Tet1/3 license the chromatin landscape of TCR-responsive genes during thymic T cell maturation. To shed ...

peripheral T-cell lymphoma (PTCL). FDA's approval of the pivotal Phase 3 protocol follows a successful Type B End-of-Phase 2 meeting, during which Yingli Pharma discussed the overall development ...

Red blood cells transport oxygen throughout your body, including to vital organs and tissues. They also help your body get rid of carbon dioxide. Too little or too many red blood cells may be ...

Cord blood cells are easily available and preserved, and they could potentially serve as a routine starting material for isolation and expansion of cells for allogenic as well as authologous ...